CoverageForm 410-K10-Q8-K13D13G13F

Functional Brands Inc. - 8-K

Filed May 28, 2026. See issuer overview · financials · original on SEC.gov ↗
Accession
0001213900-26-061761
7.018.019.01

Item 7.01 - Regulation FD Disclosure

128 words · Exhibit 99.1 attached

Item 7.01. Regulation FD Disclosure.

On May 27, 2026, Functional
Brands Inc. (the “Company”) issued a press release announcing the adjournment of the Special Meeting (as defined below), which
is furnished herewith as Exhibit 99.1 and incorporated by reference into this Item 7.01 by reference in its entirety.

The information in this Item
7.01, including the accompanying exhibit, is being furnished and shall not be deemed “filed” for purposes of Section 18 of
the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that Section.
The information in this Item 7.01 shall not be incorporated into any filing pursuant to the Securities Act of 1933, as amended, or the
Exchange Act, regardless of any general incorporation language in such filing.

Exhibit 99.1 · 960 words

EX-99.1
2
ea029243201ex99-1.htm
PRESS RELEASE DATED MAY 27, 2026

Exhibit 99.1

Functional Brands Announces Adjournment of Special
Meeting of Stockholders

Scheduled to Reconvene on June 1, 2026

Lake Oswego, OR - (May 27, 2026) - Functional Brands
Inc. (NASDAQ: MEHA), a leading innovator in wellness and performance products, today announced that the Company’s Special Meeting
of Stockholders (the “Special Meeting”) scheduled to be held on May 28, 2026 at 1:00 p.m. Eastern Time has been adjourned
to Monday, June 1, 2026 at 10:00 a.m. Pacific Time. The meeting is being conducted virtually via webcast.

No changes have been made to the proposals to be voted on by stockholders
at the Special Meeting. The Company’s proxy statement and any other materials filed by the Company with the SEC can be obtained free of
charge at the SEC’s website at www.sec.gov.

The record date for the adjourned Special Meeting continues to be April
16, 2026. No action is required by any stockholder who has previously delivered a proxy and who does not wish to revoke or change that
proxy.

The Company strongly encourages any eligible stockholder that has not
yet voted their shares, or provided voting instructions to their broker or other record holder, to do so promptly. For questions relating
to the voting of shares or to request additional or misplaced proxy voting materials, please contact the Company’s proxy solicitor:
Lioness Consulting LLC at 1-877-672-7073.

About Functional Brands Inc.

Functional
Brands Inc. (NASDAQ: MEHA) is a leading innovator in wellness and performance products dedicated to Making Everyone Healthy Again™.
The Company’s portfolio includes Kirkman®, one of the most trusted names in nutritional supplements for over 75 years with
products available in more than 35 countries; P2i™ by Kirkman® Prenatal Multivitamin & Multimineral, the first prenatal
supplement to align with FIGO standards and comply with California SB 646; and Tru2u.health, a consumer-facing telehealth and wellness
platform. Functional Brands operates an FDA-registered, cGMP-compliant manufacturing facility in Oregon. For more information, visit
www.functionalbrandsinc.com and www.kirkmangroup.com, and www.Tru2u.health

Investor Relations Contact:

[email protected]

Cautionary Note Regarding Forward Looking Statements

This news release and statements of Functional Brands’ management in
connection with this news release or related events contain or may contain “forward-looking statements” within the meaning of
Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. In this context,
forward-looking statements mean statements (including statements related to the closing, and the anticipated benefits to the Company,
of the private placement described herein) related to future events, which may impact our expected future business and financial performance,
and often contain words such as “expects,” “anticipates,” “intends,” “plans,” “believes,”
“potential,” “will,” “should,” “could,” “would,” “optimistic” or “may”
and other words of similar meaning. These forward-looking statements are based on information available to us as of the date of this news
release and represent management’s current views and assumptions. Forward-looking statements are not guarantees of future performance,
events or results and involve significant known and unknown risks, uncertainties and other factors which may be beyond our control.

Important factors that may cause actual results and outcomes to differ
materially from those contained in such forward-looking statements include, without limitation, the ability of the parties to negotiate
final terms of a definitive acquisition agreement, the closing of the contemplated asset purchase agreement, including expected conditions
to closing which are anticipated to include regulatory approvals, valuations, and future shareholder approvals; the occurrence of any
event, change or other circumstances that could give rise to the right of one or both of the Company or BullionFX (collectively, the “LOI
Parties”) to terminate the LOI agreement; the effect of such termination; the outcome of any legal proceedings that may be instituted
against LOI Parties or their respective directors or officers; the ability to obtain regulatory and other approvals and meet other closing
conditions for the asset acquisition on a timely basis or at all, including the risk that any regulatory and other approvals required
may not obtained on a timely basis or at all, or are obtained subject to conditions that are not anticipated or that could adversely affect
the combined company or the expected benefits of the transaction; the ability to obtain any necessary approval by the Company’s
stockholders on the expected schedule of the transactions contemplated by the LOI; difficulties and delays in integrating BullionFX’s
assets in the Company; prevailing economic, market, regulatory or business conditions, or changes in such conditions, negatively affecting
the parties; potential adverse reactions or changes to business relationships resulting from the announcement of the LOI and future expected
acquisition; uncertainty as to the long-term value of the common stock of the Company following the acquisition; the significant dilution
to the Company’s stockholder in connection with the acquisition; the continued availability of capital and financing following the
potential acquisition transaction; the business, economic and political conditions in the markets in which the LOI Parties operate; and
the fact that the Company’s reported earnings and financial position may be adversely affected by tax and other factors.

Readers are cautioned not to place undue reliance on these forward-looking
statements, which apply only as of the date of this news release. Potential investors should review Functional Brands’ Registration Statement
filed with the SEC on Form S-1 on October 16, 2025 and the Company’s Annual Report on Form 10-K filed with the SEC on March 27,
2026 for more complete information, including the risk factors that may affect future results, which are available for review at www.sec.gov.
Accordingly, forward-looking statements should not be relied upon as a predictor of actual results. We do not undertake to update our
forward-looking statements to reflect events or circumstances that may arise after the date of this news release, except as required by
law.

Item 8.01 - Other Events

401 words

Item 8.01. Other Events.

On May 28, 2026, Functional
Brands Inc. held its Special Meeting of Stockholders (the “Special Meeting”). As of the time the Special Meeting was convened,
there were not sufficient shares present, in person or by proxy, to constitute a quorum under the Company’s bylaws.

Accordingly, the Special Meeting
was adjourned until 10:00 a.m. Pacific Time, 1:00 p.m. Eastern Time, on Monday, June 1, 2026, virtually via webcast, to permit additional
time for the Company to solicit additional proxies and to achieve the required quorum for the transaction of business.

No changes have been made
to the proposals to be voted on at the Special Meeting. Stockholders of record as of April 16, 2026, the original record date, will continue
to be entitled to vote at the reconvened Special Meeting.

The Company strongly encourages
any eligible stockholder that has not yet voted their shares or provided voting instructions to their broker or other record holder to
do so promptly.

Forward Looking Statements

This report contains "forward-looking
statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange
Act of 1934, as amended. Forward-looking statements include, without limitation, statements regarding the reconvening of the Special Meeting,
the Company’s ability to achieve the required quorum, and the outcome of the proposals to be voted on at the Special Meeting. Words like
"believes," "expects," "anticipates," "intends," "may," "will," "would,"
or the negative thereof or other variations thereon or comparable terminology are used to identify forward-looking statements, although
not all forward-looking statements contain these words. These forward-looking statements are based on management’s current expectations
and beliefs and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those described
in the forward-looking statements. Such risks and uncertainties include, without limitation, the risk that the Company will be unable
to obtain the required quorum or stockholder approval at the reconvened Special Meeting, uncertainties relating to the proxy solicitation
process, and other risks and uncertainties described in the Company’s filings with the Securities and Exchange Commission, including its
Annual Report on Form 10-K and other periodic reports. All forward-looking statements speak only as of the date on which they are made
and the Company undertakes no duty to update or revise any forward-looking statements, whether as a result of new information, future
events or otherwise.

Item 9.01 - Financial Statements and Exhibits

31 words

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

Exhibit No.

Description

99.1

Press Release dated May 27, 2026

104

Cover Page Interactive Data File (Embedded within the Inline XBRL document)

1